The gastric cancer market was valued at USD 4.70 Billion in 2024, driven by growth in clinical trials and research across the 8 major markets. The market is expected to grow at a CAGR of 12.63% during the forecast period of 2025-2034, with the values likely to reach USD 15.44 Billion by 2034.
Base Year
Historical Year
Forecast Year
The increasing prevalence of gastric cancer owing to factors such as the growing aging population and lifestyle-related risks is leading to a higher demand for effective treatments.
The rising number of clinical trials investigating the efficacy of novel therapies and drug combinations is a significant market trend.
The growing trend toward personalized medicine and the increasing funding for cancer research is shaping the market landscape.
Value in USD Billion
2025-2034
Gastric Cancer Market Outlook
*this image is indicative*
Gastric or stomach cancer refers to a cancerous growth that occurs in the cells lining the stomach. It ranks as the third leading cause of cancer deaths and is estimated to be the fifth most frequently diagnosed cancer . Factors such as aging populations, especially in countries in Japan, and the rising lifestyle-related risks such as diet and smoking are contributing to the growing incidence of gastric cancer, which propels the market demand for effective treatments. The rising development of advanced treatment options like immunotherapies and minimally invasive surgical techniques supports the market growth. Further, the shift towards personalized medicine driven by advancements in genomics and molecular biology is anticipated to influence the market dynamics significantly.
Increasing Prevalence of Gastric Cancer Drives Market Growth
According to the American Cancer Society, around 26,890 new cases of stomach cancer and approximately 10,880 cases of deaths are estimated to occur in the United States in 2024. Further, stomach cancer is reported to account for 1.5% of all new cancer cases diagnosed in the United States annually. Recent data suggests that older adults are at a high risk of developing stomach cancer, with about 6 in every 10 individuals diagnosed with this cancer falling in the age category of 65 or above. Thus, the substantial burden of gastric cancer along with the increasing aging population is expected to drive the market growth in the coming years.
The market is witnessing several trends and developments to improve the current scenario across the 8 major markets. Some of the notable trends are as follows:
Market Breakup by Treatment Type
Market Breakup by Cancer Type
Market Breakup by Route of Administration
Market Breakup by End User
Market Breakup by Region
Market Segmentation Based on Treatment Type is Anticipated to Witness Substantial Growth
Based on the treatment type, the market is segmented into chemotherapy, immunotherapy, surgery, targeted drug therapy, and others. The chemotherapy segment represents a significant share of the market as this treatment finds its application across various stages of gastric cancer. Chemotherapy is often recommended as a first-line treatment, either alone or in combination with other therapies such as surgery and targeted drug therapy. It can help in shrinking tumors before surgery and also can manage symptoms in advanced stages of cancer and thus, is one of the most commonly utilized treatment options in the market.
The market segmentation by region includes the United States, EU-4 (Germany, France, Italy, Spain), and the United Kingdom, Japan, and India. The United States holds a major market share for gastric cancer, owing to the high prevalence of the disease and advanced healthcare infrastructure. The robust research and development activities directed at finding innovative therapies for gastric cancer further aid the market growth in the region.
Additionally, the presence of key pharmaceutical companies and substantial demand for advanced treatment modalities such as immunotherapy and targeted drug therapies contribute to the expansion of the market. Moreover, the increasing investment in cancer research by both the United States government and private sectors is poised to fuel the growth and innovation in the market in the forecast period.
The key features of the market report comprise patent analysis, clinical trials analysis, grants analysis, funding and investment analysis, and strategic initiatives by the leading key players. The major companies in the market are as follows:
AstraZeneca, a global research-based biopharmaceutical firm, has a prominent presence in the market. The company boasts a diverese portfolio of oncology drugs that target different aspects of cancer growth and progression. AstraZeneca's human monoclonal antibody Imfinzi (durvalumab) in combination with chemotherapy is being investigated for its effectiveness in treating gastric cancer.
Pfizer, Inc., headquartered in New York, United States, is a major market player focused on expanding its oncology portfolio. The company is actively engaged in exploring innovative treatments that address various cancer types, including gastric cancer. Pfizer has several ongoing clinical trials to investigate the efficacy of new treatment combinations and to expand the indications of its existing oncology drugs.
Pharmaceutical corporation Novartis AG, based in Basel, Switzerland, is one of the leading companies in the market. The company is investing heavily in developing new therapies for gastric cancer including drugs that target specific molecular pathways involved in cancer growth.
*Please note that this is only a partial list; the complete list of key players is available in the full report. Additionally, the list of key players can be customized to better suit your needs.*
Other key players in the market include Amgen Inc., Bristol-Myers Squibb Company, Eli Lily and Company, Celltrion, AbbVie Inc., and GSK plc.
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*
Get in touch with us for a customized solution tailored to your unique requirements and save upto 35%!
Explore our key highlights of the report and gain a concise overview of key findings, trends, and actionable insights that will empower your strategic decisions.
| REPORT FEATURES | DETAILS |
| Base Year | 2024 |
| Historical Period | 2018-2024 |
| Forecast Period | 2025-2034 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Treatment Type |
|
| Breakup by Cancer Type |
|
| Breakup by Route of Administration |
|
| Breakup by End User |
|
| Breakup by Region |
|
| Market Dynamics |
|
| Supplier Landscape |
|
| Companies Covered |
|
Datasheet
One User
USD 3,299
USD 2,969
tax inclusive*
Single User License
One User
USD 5,499
USD 4,969
tax inclusive*
Five User License
Five User
USD 6,999
USD 5,949
tax inclusive*
Corporate License
Unlimited Users
USD 8,199
USD 6,969
tax inclusive*
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Small Business Bundle
Growth Bundle
Enterprise Bundle
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Number of Reports: 3
20%
tax inclusive*
Small Business Bundle
Number of Reports: 5
25%
tax inclusive*
Growth Bundle
Number of Reports: 8
30%
tax inclusive*
Enterprise Bundle
Number of Reports: 10
35%
tax inclusive*
How To Order
Our step-by-step guide will help you select, purchase, and access your reports swiftly, ensuring you get the information that drives your decisions, right when you need it.
Select License Type
Choose the right license for your needs and access rights.
Click on ‘Buy Now’
Add the report to your cart with one click and proceed to register.
Select Mode of Payment
Choose a payment option for a secure checkout. You will be redirected accordingly.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Leverage cost reports for smart savings
Enhance supply chain with partnerships.
Gain insights to stay ahead and seize opportunities.
Get insights & trends for a competitive edge.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Leverage cost reports for smart savings
Enhance supply chain with partnerships.
Gain insights to stay ahead and seize opportunities.
Get insights & trends for a competitive edge.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Connect For More Information
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.
Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.
We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.
Australia
63 Fiona Drive, Tamworth, NSW
+61-448-061-727
India
C130 Sector 2 Noida, Uttar Pradesh 201301
+91-723-689-1189
Philippines
40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City,1226.
+63-287-899-028, +63-967-048-3306
United Kingdom
6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London
+44-753-713-2163
United States
30 North Gould Street, Sheridan, WY 82801
+1-415-325-5166
Vietnam
193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City
+84-865-399-124
United States (Head Office)
30 North Gould Street, Sheridan, WY 82801
+1-415-325-5166
Australia
63 Fiona Drive, Tamworth, NSW
+61-448-061-727
India
C130 Sector 2 Noida, Uttar Pradesh 201301
+91-723-689-1189
Philippines
40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City, 1226.
+63-287-899-028, +63-967-048-3306
United Kingdom
6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London
+44-753-713-2163
Vietnam
193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City
+84-865-399-124
Share